Primary mediastinal large B-cell lymphoma differential diagnosis

Revision as of 22:42, 2 January 2019 by Badria Munir (talk | contribs) (Created page with "__NOTOC__ {{Primary mediastinal large B-cell lymphoma }} {{CMG}}; {{AE}} {{Badria}} ==Overview== Primary mediastinal large B-cell lymphoma must be differentiated from other d...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Primary mediastinal large B-cell lymphoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Primary Mediastinal Large B-cell Lymphoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound]]

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Primary mediastinal large B-cell lymphoma differential diagnosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Primary mediastinal large B-cell lymphoma differential diagnosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Primary mediastinal large B-cell lymphoma differential diagnosis

CDC on Primary mediastinal large B-cell lymphoma differential diagnosis

Primary mediastinal large B-cell lymphoma differential diagnosis in the news

Blogs on Primary mediastinal large B-cell lymphoma differential diagnosis

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Primary mediastinal large B-cell lymphoma differential diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Badria Munir M.B.B.S.[2]

Overview

Primary mediastinal large B-cell lymphoma must be differentiated from other diseases that cause facial swelling, superior vena cava syndrome, and fever, night sweats and weightloss such as hodgkin's lymhoma, thymoma], and other non hodgkin's lymphoma.

Differentiating [Disease name] from other Diseases

Primary mediastinal large B-cell lymphoma must be differentiated from other diseases that cause facial swelling, superior vena cava syndrome, and fever, night sweats and weightloss such as hodgkin's lymhoma, thymoma], and other non hodgkin's lymphoma. The differentiation is determined on the basis of biopsy findings and immunophenotype, which are as follows:

References

  1. Kodama T, Watanabe S, Sato Y, Shimosato Y, Miyazawa N (January 1986). "An immunohistochemical study of thymic epithelial tumors. I. Epithelial component". Am. J. Surg. Pathol. 10 (1): 26–33. PMID 2420219.
  2. von Wasielewski R, Mengel M, Fischer R, Hansmann ML, Hübner K, Franklin J, Tesch H, Paulus U, Werner M, Diehl V, Georgii A (October 1997). "Classical Hodgkin's disease. Clinical impact of the immunophenotype". Am. J. Pathol. 151 (4): 1123–30. PMC 1858022. PMID 9327746.
  3. Suster S, Rosai J (February 1991). "Thymic carcinoma. A clinicopathologic study of 60 cases". Cancer. 67 (4): 1025–32. PMID 1991250.
  4. Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM, Bloomfield CD, Cazzola M, Vardiman JW (May 2016). "The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia". Blood. 127 (20): 2391–405. doi:10.1182/blood-2016-03-643544. PMID 27069254.
  5. Mann JR, Raafat F, Robinson K, Imeson J, Gornall P, Sokal M, Gray E, McKeever P, Hale J, Bailey S, Oakhill A (November 2000). "The United Kingdom Children's Cancer Study Group's second germ cell tumor study: carboplatin, etoposide, and bleomycin are effective treatment for children with malignant extracranial germ cell tumors, with acceptable toxicity". J. Clin. Oncol. 18 (22): 3809–18. doi:10.1200/JCO.2000.18.22.3809. PMID 11078494.